Clinical Research Products Management Center CRPMC Tender

• Country: USA
• Summary: Clinical Research Products Management Center CRPMC
• UST Ref No: 133323257
• Deadline: 23 Jan 2026
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: 75N93026R00003
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Introduction
  This is a Small Business Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are small businesses; HUBZone small businesses; service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization that is not considered a small business under the applicable NAICS code should not submit a response to this notice.
  Background
  The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) plans, sponsors, and directs extramural research programs involving evaluation of the safety and efficacy of vaccines, therapeutics, and prevention modalities. Through these programs, clinical trials at more than 145 clinical research sites are supported.
  NIAID is required to provide oversight and management of investigational study product for clinical trials to ensure compliance with all applicable regulations, including Title 21 Code of Federal Regulations (CFR) Part 312 and Human Subjects Protection Title 45 CFR Part 46. Investigational study product management includes the receipt, storage, handling, and distribution of investigational product. These activities are mission critical functions and high priority in ensuring the integrity of study products used in human clinical trials.
  The Clinical Research Products Management Center contract was initially awarded in 1988. The current contract number 75N...
• Documents:

 Tender Notice